Hologic (NSDQ:HOLX) said today that a study of women screened for breast cancer over multiple years using its Genius 3D mammography system showed a significant drop in recalls.
The findings, which were published in an advance print of the journalJAMA Oncology this month, indicated that the use of Marlborough, Mass.-based Hologic’s 3D mammography unit resulted in less call backs, more cancer cases found in recalled patients and fewer cancers diagnosed between regular screenings.
